Retrospective Real-World Analysis of the Primary Safety Outcomes in Venous Thromboembolism of High-Risk Major Bleeding Cancer Patients Receiving Therapeutic Anticoagulation
Blood (2020) 136 (Supplement 1): 15–16.
Currently there are no citedby results. Try again later.
